Objective: Low-risk gestational trophoblastic neoplasia (GTN) is generally treated with single agent chemotherapy and methotrexate (MTX) as a first-line therapy. Vitamin A helps to increase trophoblast cell regression, as well as to decrease β-hCG levels. Vitamin A also increases the effectiveness of MTX by inducing more malignant cell death than MTX alone. Therefore, the aim of the current study was to analyze the changes in β-hCG levels in low-risk GTN patients following vitamin A administration. Methods: This study was a randomized clinical trial, which examined initial serum vitamin A and β-hCG levels in GTN patients before and after three cycles of MTX therapy. Patients were given vitamin A supplementation of 6,000 IU (1.8 mg RAEs) per day, and the changes in serum β-hCG were observed after three cycles. Patients were grouped by β-hCG levels (decreased or stagnant). Results: A total of 32 low-risks GTN patients were divided into the intervention group (16 patients who received vitamin A supplementation) and the control group (16 patients who did not receive vitamin A supplementation). In the intervention group, the average initial β-hCG level was 170,949.3 ± 354,452.1 mIU/mL, and the average β-hCG post-cycle level was 1,611.9 ± 3,652.5 mIU/mL. In the control group, the average initial β-hCG level was 178,834.1 ± 2913844.6 mIU/mL, and the average β-hCG post-cycle level was 25,388.5 ± 58,437.7 mIU/mL. Conclusion: In patients with low-risk GTN who underwent MTX chemotherapy, the levels of β-hCG and the incidence of chemo resistance in the intervention group were lower than those in the control group. Older age may also influence the incidence of chemo resistance in GTN patients. Oral administration of 6,000 IU vitamin A could help to reduce β-hCG levels in low-risk GTN patients who receive MTX chemotherapy.
Hidayat, Y., Darmadi A, E., Rachmayati, S., Kusumah, W., Djuwantono, T., Pramatirta, A., & Suardi, D. (2020). Efficacy of Oral Vitamin A in Reducing β-hCG Levels in Low-Risk Gestational Trophoblastic Neoplasia Patients. Asian Pacific Journal of Cancer Prevention, 21(11), 3325-3329. doi: 10.31557/APJCP.2020.21.11.3325
MLA
Yudi Mulyana Hidayat; Eppy Darmadi A; Sylvia Rachmayati; Windy Puspa Kusumah; Tono Djuwantono; Akhmad Yogi Pramatirta; Dodi Suardi. "Efficacy of Oral Vitamin A in Reducing β-hCG Levels in Low-Risk Gestational Trophoblastic Neoplasia Patients". Asian Pacific Journal of Cancer Prevention, 21, 11, 2020, 3325-3329. doi: 10.31557/APJCP.2020.21.11.3325
HARVARD
Hidayat, Y., Darmadi A, E., Rachmayati, S., Kusumah, W., Djuwantono, T., Pramatirta, A., Suardi, D. (2020). 'Efficacy of Oral Vitamin A in Reducing β-hCG Levels in Low-Risk Gestational Trophoblastic Neoplasia Patients', Asian Pacific Journal of Cancer Prevention, 21(11), pp. 3325-3329. doi: 10.31557/APJCP.2020.21.11.3325
VANCOUVER
Hidayat, Y., Darmadi A, E., Rachmayati, S., Kusumah, W., Djuwantono, T., Pramatirta, A., Suardi, D. Efficacy of Oral Vitamin A in Reducing β-hCG Levels in Low-Risk Gestational Trophoblastic Neoplasia Patients. Asian Pacific Journal of Cancer Prevention, 2020; 21(11): 3325-3329. doi: 10.31557/APJCP.2020.21.11.3325
)